Department(s)
School of Public Policy
Document Type
Article
Version Deposited
Published version
Publication Date
5-1-2024
Keywords
community health, coronavirus vaccination, COVID-19, minority health, mobile-based approach, vaccine confidence
Abstract
We developed and tested MivacunaLA/MyshotLA, a community-informed mobile phone intervention, to increase COVID-19 vaccination among Latino parents/caretakers of minors in under-resourced areas of Los Angeles by addressing misinformation and building trust. We recruited Latino parents/caregivers with at least one unvaccinated child in East and South Los Angeles in the summer of 2021 and evaluated MivacunaLA as a randomized controlled trial with a wait-list control group. A difference-in-difference analysis showed Latino parents/caregivers that participated in MivacunaLA (n = 246), in comparison to the control group, were 15 percentage points more likely (p = 0.04) to report vaccination of minors aged 12–17 years, and 12 percentage points more likely (p = 0.03) to report a positive intention to vaccinate minors aged 2–11 years (when COVID-19 vaccines became available). Mobile phone-delivered digital interventions using videos and culturally tailored educational material to promote COVID-19 vaccine confidence can be an effective way to combat misinformation and deliver timely information to marginalized communities. Community-based participatory research approaches are crucial to advance health equity among minority communities, especially immigrant Spanish-speaking underserved communities.
Publication Title
Vaccines
E-ISSN
2076393X
Volume
12
Issue
5
DOI
10.3390/vaccines12050511
Recommended Citation
Castellon-Lopez, Y. M., Klomhaus, A. M., Garcia, C., Marquez, D., Avila, H., Gravette, H., Lopez-Chang, R., Ortega, B., Norris, K. C., Brown, A. F., & Blanco, L. (2024). MivacunaLA (MyshotLA): A Community-Partnered Mobile Phone Intervention to Improve COVID-19 Vaccination Behaviors among Low-Income, Spanish-Speaking, and Immigrant Latino Parents or Caregivers. Vaccines, 12(5), 511. https://doi.org/10.3390/vaccines12050511
Comments
Publication can be accessed at this link: https://10.3390/vaccines12050511